Lawmakers debate GLP-1 regulation, expansion

(The Center Square) – Lawmakers pushed for more regulations and safety standards on popular weight loss medications, including GLP-1 prescriptions, at an event in Washington, D.C., on Wednesday.

Rep. Rudy Yakym, R-Ind., touted the Safe Drugs Act, legislation that would require compounding pharmacies to follow the same regulations as traditional drug manufacturers.

Compounding pharmacies are large drug manufacturers, typically producing more than 100 different medications and a popular producer of GLP-1 medications.

The legislation would require the facilities to undergo annual FDA inspections and disclose the materials included in manufactured drugs.

“As it relates to health and safety in this country, we should be raising the standards for safety,” Yakym said. “The ability to just simply pass an FDA inspection before you start manufacturing, I mean, that’s a basic fundamental requirement.”

Scott Kahan, director of the ...